The Rapid Blog

Resources

Master Series: What to Expect and How to Address Data Integrity Audits

March 11, 2020 By Rapid Micro Biosystems

New FDA regulations have put concerns about Data Integrity in QC micro labs and pharma manufacturing front and center. In response, Rapid Micro..

Read More

Master Series: What to Expect and How to Address Data Integrity Audits

March 11, 2020 By Rapid Micro Biosystems

New FDA regulations have put concerns about Data Integrity in QC micro labs and pharma manufacturing front and center. In response, Rapid Micro..

Read More

Validation of the Growth Direct System to Perform Pharmaceutical In-process Bioburden Analysis

October 29, 2019 By Rapid Micro Biosystems

Pharmaceutical in-process testing can be a significant percentage of the workload in the microbiological QC department. Each microbial sample test..

Read More

Rapid Micro Biosystems sera présent au congrès international A3P à Biarritz, France / Rapid Micro Biosystems to Exhibit at the A3P International Congress in Biarritz, France

October 2, 2019 By Rapid Micro Biosystems

Rapid Micro Biosystems (RMB) sera présent au congrès international A3P du 15 au 17 octobre à Biarritz, France. RMB est ravi de participer à cette..

Read More

Facilitating Data Integrity Compliance with a Rapid Micro Method

September 24, 2019 By Rapid Micro Biosystems

The phrase “Data Integrity” was unknown in the QC microbiology lab until recently. Findings with HPLC systems where stored data was reworked to..

Read More

How Growth Direct™ is Helping Biogen Move Their Business Forward

February 28, 2019 By Rapid Micro Biosystems

The American Healthcare Leader (AHL) recently sat down with Melissa Seymour, Vice President of Global Quality Control at Biogen, to discuss their..

Read More